Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck & Co.
Pharma
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC
For now, approval in the PD-L1-positive population makes Trodelvy’s TNBC label broader than its rival. But AZ and Daiichi plan to catch up.
Angus Liu
Jun 24, 2026 5:00pm
Merck's Welireg expands in kidney cancer with adjuvant nod
Jun 15, 2026 11:46am
Gilead's Trodelvy stumbles in first-line NSCLC
Jun 9, 2026 11:14am
Fierce Biotech
At CNPV hearing, industry support meets ‘concern’ from experts
Jun 5, 2026 5:00am
At ASCO, China biotech industry cements its coming of age
Jun 3, 2026 8:50am
Merck lays off 88 staffers tied to New Jersey headquarters
Jun 2, 2026 11:10am
